Life Sciences

SVB buys Leerink for $280M, boosting its life sciences business

November 15, 2018

There’s a lot of talk at the moment about the emerging overlap between the tech and life sciences sectors, and now there’s a big player with extensive expertise in both areas. Silicon Valley Bank parent SVB is buying prominent life sciences investor Leerink Partners for..

Novartis files for Alcon spinoff, citing aging population and developing countries as top growth prospects

November 15, 2018

When Novartis said in June that it would spin off its long-struggling eye-care unit, Alcon, CEO Vas Narasimhan declined to estimate what the valuation on such a transaction might be. But his predecessor, Joe Jimenez, said last year that he thought Alcon could be worth..

Google to retake DeepMind’s AI healthcare unit, as it moves toward a cohesive strategy

November 14, 2018

Days after poaching a health system executive to pull together its disparate healthcare ventures, Google moved to reabsorb DeepMind’s health business, including those behind its mobile app for doctors and nurses. DeepMind, Alphabet’s U.K.-based artificial intelligence company, announced in a blog post that the team..

Bayer’s animal and consumer health units look weaker, yes. But don’t expect selloffs: CEO

November 14, 2018

Industry watchers have suggested that breaking up Bayer is a good option for its pharmaceutical business. Now, a gloomier 2018 outlook for the company’s animal health and consumer units might have just padded the arguments for those split-up advocates. For the first full quarter since..

Sobi buys rights to AstraZeneca infant drug for $1.5 billion upfront

November 14, 2018

AstraZeneca has taken another step to refocus on priority drugs by selling U.S. rights to a treatment for infant lung infections to Swedish Orphan Biovitrum for an upfront fee of $1.5 billion. Around 130 AstraZeneca staff will transfer to Sobi as the Swedish company, widely..

With $98M investment, Nestlé bumps up its Aimmune stake to 19%

November 13, 2018

Two years after Nestlé Health Science poured $145 million into Aimmune, the company is boosting its total investment in the food allergy-focused biotech to $273 million. This brings Nestlé Health’s stake in Aimmune to 18.9% as the company prepares an FDA filing for its peanut..

Special Report—The top 10 cancer drug makers of 2024

November 13, 2018

At first glance, the list of cancer drug makers predicted to head the field by 2024 may not look so different from the list of top-selling cancer drug makers in 2017. The cast of characters is largely the same, and Roche, Celgene and Bristol-Myers Squibb—which..

Merck quadruples Gardasil supply in China contract

November 12, 2018

Facing buoyant demand in China for its HPV vaccines on the back of its Gardasil 9 launch, Merck & Co. has promised almost quadrupled supply in the coming years in a renewed contract with a local distributor. But that still might not be enough to..

AstraZeneca chief says Europe should pay more for drugs—and the U.S. should pay less

November 9, 2018

President Donald Trump has routinely bashed “global freeloading” on pharmaceuticals, and his administration last month unveiled a plan to try and lower some U.S. drug prices to international levels. Now, a top pharma CEO says he’s right—at least in principle. In an interview with Bloomberg..

Consumers may not like health data sharing, but pharma sure does

November 8, 2018

When a recent media report detailed how Clorox used data derived from smart thermometers to send targeted digital ads, consumers and critics were aghast. People were dismayed that personal health data like temperature—in this case, aggregate de-identified information by zip codes—would be used for advertising…